Clinic vs. Basic Research: CIRM Funding Priorities
This item is part of the continuing coverage today of the board meeting of the California stem cell agency based on its audiocast.
The California stem cell agency today set a goal of raising roughly $240 million by privately selling state bonds over the next two years, preserving both its touted efforts to push development of therapies in the clinic and …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.